Real-World Effectiveness and Safety of Belantamab Mafodotin Monotherapy in Triple-Class Refractory Multiple Myeloma

B-cell maturation antigen (BCMA) is a promising therapeutic target for multiple myeloma (MM). The aim of this study was to assess the effectiveness and tolerability of monotherapy with the conjugated anti-BCMA monoclonal antibody belantamab mafodotin in triple-class refractory patients with MM in re...

Descripción completa

Detalles Bibliográficos
Autores principales: Ntanasis-Stathopoulos, Ioannis, Malandrakis, Panagiotis, Fotiou, Despina, Migkou, Magdalini, Theodorakakou, Foteini, Roussou, Maria, Eleutherakis-Papaiakovou, Evangelos, Spiliopoulou, Vassiliki, Kastritis, Efstathios, Terpos, Evangelos, Dimopoulos, Meletios-Athanasios, Gavriatopoulou, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380484/
https://www.ncbi.nlm.nih.gov/pubmed/37511588
http://dx.doi.org/10.3390/ijms241411829

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380484/
https://www.ncbi.nlm.nih.gov/pubmed/37511588
http://dx.doi.org/10.3390/ijms241411829

Ejemplares similares